Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-13

Clinical Trial Update: Clinical Trial on the Effects of Bifidobacterium Infantis in Active Celiac Disease [NA]

View source ↗

Summary

A completed clinical trial evaluated the effects of the probiotic Bifidobacterium Infantis in active celiac disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bifidobacterium infantis (Bifidobacterium infantis)

Snippet

Sponsor: Bai, Julio M.D. | Conditions: Celiac Disease | NA | Status: COMPLETED